Laser Photonics receives $1.05M tablet drilling order
Analysis based on 6 articles · First reported Aug 24, 2026 · Last updated Aug 24, 2026
The order is a modest revenue win for Laser Photonics, potentially strengthening its position in the pharmaceutical laser drilling market and supporting future orders. The announcement may have a slightly positive effect on LASE stock, though the financial impact is limited given the order size.
Laser Photonics Corporation announced on August 24, 2026 that its subsidiary Laser Photonics — CMS Laser received a purchase order valued at approximately $1.05 million from a U.S.-based pharmaceutical company for a TD-70 high-speed pharmaceutical tablet drilling system. The order, a first-time purchase by this customer, includes the drilling system along with tablet handling tooling, conveyor transport, a full IQ/OQ/PQ validation package, and on-site installation. The TD-70 drills precision orifices in controlled-release tablets, with throughput up to 70,000 tablets per hour and dual-camera inspection. The system will be built at Laser Photonics — CMS Laser's facility in Winter Park, Florida. The order follows Laser Photonics' May 2026 expansion into precision medical device manufacturing. The company also intends to expand its investment in Laser Photonics — CMS Laser to support growth and product development. Ann Tewari, Interim President, commented on the order's significance as a validation of the platform and a foothold in a new customer's operations.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard